Sahmeddini Mohammad Ali, Jamshidi Mina, Panah Ashkan, Salari Mehrdad, Banifatemi Mahsa, Kanaani Nejad Fatemeh
Anesthesiology and Critical Care Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Strabismus. 2024 Dec;32(4):243-251. doi: 10.1080/09273972.2024.2368703. Epub 2024 Jul 8.
: Postoperative agitation is a common complication of sevoflurane anesthesia in children and might lead to self-harm and recovery disruption. This study aimed to compare the prophylactic effect of dexmedetomidine and remifentanil on postoperative agitation after anesthesia with sevoflurane. : In this clinical trial, 60 children aged 2 to 7 years with ASA class І, II, candidates for elective strabismus surgery, were randomly assigned to three groups using block randomization. Patients in the first group D received 0.5 µgr/kg dexmedetomidine, the second group R received 0.1 µgr/kg remifentanil, and another group C received normal saline at the end of anesthesia. Children's agitation degree was measured by the Pediatric Anesthesia Emergence Delirium (PAED) scales and the 4-point agitation scale at the time of extubation, entering the recovery room, 10, 20, and 30 minutes after entrance. Data analysis was performed using descriptive and inferential statistical tests. : The postoperative agitation and pain were significantly lower among children who received dexmedetomidine compared with those in remifentanil and the control group ( < .001). It was observed that the administration of dexmedetomidine at the end of anesthesia significantly decreased the incidence of postoperative agitation ( < .001). None of the patients in group D had a PAED score of over 12. : Based on PAED and the 4-point scales, none of the cases in group D had experienced postoperative agitation; this made a significant statistical difference compared with groups C and R (-value <. 001). Although both dexmedetomidine and remifentanil can prevent and attenuate postoperative agitation, dexmedetomidine administration seems significantly more effective.
术后躁动是小儿七氟醚麻醉常见的并发症,可能导致自我伤害及影响恢复。本研究旨在比较右美托咪定和瑞芬太尼对七氟醚麻醉术后躁动的预防效果。
在这项临床试验中,60例年龄在2至7岁、ASA分级为Ⅰ、Ⅱ级、拟行择期斜视手术的患儿,采用区组随机化方法随机分为三组。第一组(D组)患儿在麻醉结束时接受0.5μg/kg右美托咪定,第二组(R组)接受0.1μg/kg瑞芬太尼,另一组(C组)接受生理盐水。在拔管时、进入恢复室时、进入恢复室后10、20和30分钟,采用小儿麻醉苏醒期谵妄(PAED)量表和4分躁动量表测量患儿的躁动程度。数据分析采用描述性和推断性统计检验。
与瑞芬太尼组和对照组相比,接受右美托咪定的患儿术后躁动和疼痛明显更低(P<0.001)。观察发现,麻醉结束时给予右美托咪定可显著降低术后躁动的发生率(P<0.001)。D组没有患者的PAED评分超过12分。
根据PAED量表和4分量表,D组无一例发生术后躁动;与C组和R组相比,这有显著统计学差异(P值<0.001)。虽然右美托咪定和瑞芬太尼都能预防和减轻术后躁动,但右美托咪定的给药似乎明显更有效。